128 related articles for article (PubMed ID: 12407750)
1. Detection of K-ras and p53 mutations by "mutant-enriched" PCR-RFLP.
Schuermann M
Methods Mol Med; 2003; 75():325-33. PubMed ID: 12407750
[No Abstract] [Full Text] [Related]
2. Facilitated detection of oncogene mutations from exfoliated tissue material by a PNA-mediated 'enriched PCR' protocol.
Behn M; Thiede C; Neubauer A; Pankow W; Schuermann M
J Pathol; 2000 Jan; 190(1):69-75. PubMed ID: 10640994
[TBL] [Abstract][Full Text] [Related]
3. Analysis of K-RAS and P53 mutations in sputum samples.
Gao W; Keohavong P
Methods Mol Biol; 2005; 291():217-33. PubMed ID: 15502226
[TBL] [Abstract][Full Text] [Related]
4. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
Behn M; Qun S; Pankow W; Havemann K; Schuermann M
Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
[TBL] [Abstract][Full Text] [Related]
5. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
6. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers.
Kersting M; Friedl C; Kraus A; Behn M; Pankow W; Schuermann M
J Clin Oncol; 2000 Sep; 18(18):3221-9. PubMed ID: 10986054
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis.
Keohavong P; Gao WM; Zheng KC; Mady H; Lan Q; Melhem M; Mumford J
Anal Biochem; 2004 Jan; 324(1):92-9. PubMed ID: 14654050
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Mutations in K-ras and p53 Genes in Sputum and Plasma Samples.
Zhang L; Gao W; Keohavong P
Methods Mol Biol; 2020; 2102():373-394. PubMed ID: 31989568
[TBL] [Abstract][Full Text] [Related]
9. PCR bias toward the wild-type k-ras and p53 sequences: implications for PCR detection of mutations and cancer diagnosis.
Barnard R; Futo V; Pecheniuk N; Slattery M; Walsh T
Biotechniques; 1998 Oct; 25(4):684-91. PubMed ID: 9793653
[TBL] [Abstract][Full Text] [Related]
10. Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR.
Toyooka S; Tsukuda K; Ouchida M; Tanino M; Inaki Y; Kobayashi K; Yano M; Soh J; Kobatake T; Shimizu N; Shimizu K
Oncol Rep; 2003; 10(5):1455-9. PubMed ID: 12883723
[TBL] [Abstract][Full Text] [Related]
11. Enriched SSCP: a highly sensitive method for the detection of unknown mutations. Application to the molecular diagnosis of lung cancer in sputum samples.
Marchetti A; Buttitta F; Carnicelli V; Pellegrini S; Bertacca G; Merlo G; Bevilacqua G
Diagn Mol Pathol; 1997 Aug; 6(4):185-91. PubMed ID: 9360839
[TBL] [Abstract][Full Text] [Related]
12. Screening of mutations in the ras family of oncogenes by polymerase chain reaction-based ligase chain reaction.
MartÃnez A; Lehman TA; Modali R; Mulshine JL
Methods Mol Med; 2003; 74():187-200. PubMed ID: 12415694
[No Abstract] [Full Text] [Related]
13. Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by point-EXACCT.
Somers VA; Thunnissen FB
Methods Mol Med; 2003; 75():305-23. PubMed ID: 12407749
[No Abstract] [Full Text] [Related]
14. Detection of p53 and K-ras mutations in sputum of individuals exposed to smoky coal emissions in Xuan Wei County, China.
Keohavong P; Lan Q; Gao WM; Zheng KC; Mady HH; Melhem MF; Mumford JL
Carcinogenesis; 2005 Feb; 26(2):303-8. PubMed ID: 15564291
[TBL] [Abstract][Full Text] [Related]
15. [Mutations of ras and p53 genes in human non-small cell lung cancer cell lines and their clinical significance].
Mitsudomi T; Oyama T; Gazdar AF; Minna JD; Okabayashi K; Shirakusa T
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):944-7. PubMed ID: 1361656
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
17. Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction.
Lehman TA; Scott F; Seddon M; Kelly K; Dempsey EC; Wilson VL; Mulshine JL; Modali R
Anal Biochem; 1996 Aug; 239(2):153-9. PubMed ID: 8811898
[TBL] [Abstract][Full Text] [Related]
18. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.
Schiller JH; Adak S; Feins RH; Keller SM; Fry WA; Livingston RB; Hammond ME; Wolf B; Sabatini L; Jett J; Kohman L; Johnson DH
J Clin Oncol; 2001 Jan; 19(2):448-57. PubMed ID: 11208838
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection.
Isobe T; Hiyama K; Yoshida Y; Fujiwara Y; Yamakido M
Jpn J Cancer Res; 1994 Dec; 85(12):1240-6. PubMed ID: 7852188
[TBL] [Abstract][Full Text] [Related]
20. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA).
Takeda S; Ichii S; Nakamura Y
Hum Mutat; 1993; 2(2):112-7. PubMed ID: 8318987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
